Newsletter - September 1, 2016
Does it Matter if Your CRO is Big or Small?
A common question asked when choosing a suitable contract research organization (CRO) is if one should go with a big CRO or a small CRO. There are 751 CROs in the World with about half of them or 332 in the US. Of these, the top 10 CROs account for about 57% of the total revenue in the industry; 9 of these top 10 CROs are based in the US. About 15 CROs are considered mid-size; all of which are located in the US or Western Europe. Read More..
Another Drug Price Hike, Another Hollow Debate: Mylan’s EpiPen
News in the past week has been rife with another drug company gouging the price of a critical life-saving drug with no apparent reason. In a span of 6 years, Mylan raised the price of its EpiPen by 400%, and once again we had all those debates of how pharma companies profit from artificial monopolies and naked greed. This is not the first time and this will not be the last either. We heard it last year for daraprim whose price was hiked 5000%, its CEO was in trouble with the law and politicians; but an year later daraprim still costs the same $750 a pill. Read More..
Does it Matter if Your CRO is Big or Small?
A common question asked when choosing a suitable contract research organization (CRO) is if one should go with a big CRO or a small CRO. There are 751 CROs in the World with about half of them or 332 in the US. Of these, the top 10 CROs account for about 57% of the total revenue in the industry; 9 of these top 10 CROs are based in the US. About 15 CROs are considered mid-size; all of which are located in the US or Western Europe. Read More..
Another Drug Price Hike, Another Hollow Debate: Mylan’s EpiPen
News in the past week has been rife with another drug company gouging the price of a critical life-saving drug with no apparent reason. In a span of 6 years, Mylan raised the price of its EpiPen by 400%, and once again we had all those debates of how pharma companies profit from artificial monopolies and naked greed. This is not the first time and this will not be the last either. We heard it last year for daraprim whose price was hiked 5000%, its CEO was in trouble with the law and politicians; but an year later daraprim still costs the same $750 a pill. Read More..
